Quantcast

Latest IBD Stories

2014-04-30 10:21:24

May provide therapeutic target for treating inflammatory bowel disease and preventing colitis-associated colorectal cancer, according to new research published in the American Journal of Pathology The adhesion molecule CD146 plays a vital role in inflammation and offers a promising therapeutic target for treating inflammatory bowel disease (IBD) as well as preventing colitis-associated colorectal cancer, say scientists. Targeting CD146 with anti-CD146 antibody AA98, especially in...

2014-03-28 11:32:58

A novel method for distinguishing different types of bowel disease using the stool samples of patients has been created by a group of researchers in the UK. It works by analysing the chemical compounds emitted from the samples and could provide cheaper, quicker and more accurate diagnoses, at the point of care, for a group of diseases that have, up until now, been very hard to distinguish. The preliminary results of the test, which have been published today, 28 March, in IOP...

2014-03-10 16:31:55

Foundation Champions Innovation & Collaboration to Accelerate IBD Breakthroughs OAKLAND, Calif., March 10, 2014 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation's 2014 Innovations Symposium: Taming the Microbiome will take place July 15 - 16, 2014, at the Union Square Marriott in San Francisco. The annual event brings together influential and collaborative researchers and institutions, with the common goal of curing Inflammatory Bowel Disease (IBD), a disease that affects...

2014-03-03 08:32:34

CCFA Researchers Map Out Strategies to New Drugs and Individualized Therapy for Crohn's Disease and Ulcerative Colitis NEW YORK, March 3, 2014 /PRNewswire/ -- High-powered research teams supported by the Crohn's & Colitis Foundation of America (CCFA) are gearing up for an ambitious new goal: developing individualized treatment approaches for patients with Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD), through their Genetics and...

2014-01-07 04:21:03

LONDON, January 7, 2014 /PRNewswire/ -- ~ ST10 strongly demonstrates potential to be (1) the only effective oral treatment for ferrous intolerant IDA patients and (2) an effective alternative to intravenous iron treatment ~ Shield Therapeutics (Shield), an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces strongly positive top-line data from...

2013-09-24 23:19:33

Reportbuyer.com just published a new market research report: Inflammatory Bowel Diseases: World Drug Market 2013-2023. London (PRWEB) September 24, 2013 Report Details Medicines for bowel inflammation - you explore R&D and potential sales What's the future for treating inflammatory bowel diseases (IBD)? Visiongain's updated report gives you revenue predictions from 2013, helping you stay ahead. There you find financial results, R&D trends, opportunities, and potential...

2013-08-30 23:19:10

The physicians at Los Angeles Colon and Rectal Surgical Associates (http://colon92010.com) have added a new section to their website to help assist their patients in understanding a number of colorectal diseases. The section is focused on patient education specific to the diseases of colon cancer, irritable bowel syndrome, and inflammatory bowel disease. Beverly Hills, California (PRWEB) August 30, 2013 The colorectal surgeons of Los Angeles Colon and Rectal Surgical Associates...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related